The high SLC1A5 expression in tumor cells may modulate tumor-infiltrating immune cells, as the knockdown of SLC1A5 expression recruits M2 macrophage infiltration to increase immunotherapy efficiency in pancreatic adenocarcinoma [5]. This evidence concerns the gene SLC1A5 and pancreatic adenocarcinoma.